Safety of a 2-visit cluster schedule of venom immunotherapy in outpatients at risk of life-threatening anaphylaxis

J Investig Allergol Clin Immunol. 2010;20(1):91-2.

Authors

I Sánchez-Machín¹, C Moreno, R González, J Iglesias-Souto, E Pérez, V Matheu

Affiliation

¹ Allergy Service, Hospital Universitario NS Candelaria, Santa Cruz de Tenerife, Spain.

PMID: 20232782

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Adult
Aged
Anaphylaxis / etiology*
Bee Venoms / administration & dosage*
Bee Venoms / immunology
Child
Desensitization, Immunologic / adverse effects*
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Outpatients
Risk

Substances

Bee Venoms